Benchmark helps deliver improved healthcare products and welfare services to the global aquaculture and livestock industries. Rising demand from clients for its products and services to manage sustainability practice and performance underlines BMK's opportunity for significant organic and external growth.

24 May 2023

Benchmark Holdings - Q2 / HY Results - Investor Presentation video - 23 May 2023

Benchmark Holdings plc, the aquaculture biotechnology company, conducted an investor presentation following publication of their Q2 & Interim results for the period to 31st March 2023.

Trond Williksen, CEO, and Septima Maguire, CFO ran investors through highlights of the period, which included strong performance across the three business divisions - Genetics, Advanced Nutrition and Health. They provided a detailed financial review and updated viewers on plans maintain a dual listing on Euronext Growth Oslo and AIM for the foreseeable future. Management also answered a range of investors questions.

The video has been divided into chapters as below:
0:00:00 Introduction
0:00:46 Q2 FY23 highlights
0:05:32 Operational Update in Genetics
0:13:57 Operational Update in Advanced Nutrition
0:17:20 Operational Update in Health
0:21:36 Financial Update
0:27:50 Outlook
0:37:33 Questions & Answers

Return to Benchmark Holdings

Register to be first

Get research on the companies that interest you straight to your inbox

Equity Development is a partner to successful companies looking to enhance their investor relations. Our top-rated analysts produce best in class investment research. Based in London, UK, we help our clients connect with investors via presentations and interviews.

Equity Development Limited 2nd Floor, Park House, 16-18 Finsbury Circus, London, EC2M 7EB

Website design & development by Breckenridge